SCM
KRSA

Sarissa Capital Management’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Sarissa Capital Management’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,786
Closed -$2.86M – 13
2019
Q2 		$2.86M Buy
+1,786
New +$505K 0.36% 10

Other funds holding KRSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Sarissa Capital Management's KRSA Position: Q3 2019 in Review

Sarissa Capital Management sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q3 2019, closing a stake of 1,786 shares — an estimated $2.86M sold.

Sarissa Capital Management first reported a position in KRSA in Q2 2019 and held it in 1 quarter. The position peaked at $2.86M in Q2 2019. 86 funds tracked by Wall St. Rank hold KRSA as of Q3 2019.

  • Sarissa Capital Management reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Sarissa Capital Management sold 1,786 Korsana Biosciences, Inc. Common Stock shares in Q3 2019, an estimated $2.86M.
  • Sarissa Capital Management first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Sarissa Capital Management's Korsana Biosciences, Inc. Common Stock position peaked at $2.86M in Q2 2019.
  • 86 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q3 2019.

Based on Sarissa Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.